Document is current
Any future updates will be listed below
-
Authors
Dadhania, Vipulkumar
Gonzalez, Daniel
Yousif, Mustafa
Cheng, Jerome
Morgan, Todd M.
Spratt, Daniel E.
Reichert, Zachery R.
Mannan, Rahul
Wang, Xiaoming
Chinnaiyan, Anya
Cao, Xuhong
Dhanasekaran, Saravana M.
Chinnaiyan, Arul M.
Pantanowitz, Liron
Mehra, Rohit http://orcid.org/0000-0002-6955-8884
- License Information
-
More Information
Article History
Received: 3 November 2021
Accepted: 17 April 2022
First Online: 5 May 2022
Declarations
:
: This study was performed under institutional review board-approved protocols (with a waiver of informed consent). Approval was granted by the Ethics Committee of University of Michigan School of Medicine. (Approval No.: RBMED # 2001–0155).
: Not applicable.
: LP is on the scientific advisory board for Ibex and NTP and serves as a consultant for Hamamatsu. The University of Michigan has been issued a patent on the detection of ETS gene fusions in prostate cancer, on which RoM and AMC are listed as co-inventors. All other authors have no relevant disclosures.
